AGIOS PHARMACEUTICALS, INC.·4

Aug 13, 4:12 PM ET

Smith Cynthia 4

4 · AGIOS PHARMACEUTICALS, INC. · Filed Aug 13, 2024

Insider Transaction Report

Form 4
Period: 2024-08-11
Transactions
  • Exercise/Conversion

    Common stock

    2024-08-11+2,3027,992 total
  • Exercise/Conversion

    Restricted stock units

    2024-08-112,3022,302 total
    Common stock (2,302 underlying)
Footnotes (2)
  • [F1]Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.
  • [F2]The restricted stock units were granted on August 11, 2022. Beginning on August 11, 2023, the shares underlying the restricted stock units will vest in three equal annual installments.

Documents

1 file
  • 4
    wk-form4_1723579952.xmlPrimary

    FORM 4